Boston Urogynecology Associates, 725 Concord Ave. Suite 1200 — Cambridge, Massachusetts

Boston Urogynecology Associates, 725 Concord Ave. Suite 1200 is a clinical research site located in Cambridge, Massachusetts, United States 02138.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Boston Urogynecology Associates, 725 Concord Ave. Suite 1200 has participated in 1 clinical trials.

Therapeutic areas: Cystoscopy, Phenazopyridine.

Sponsors: Boston Urogynecology Associates.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cambridge

Browse all research sites in Massachusetts · View every site in Cambridge

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston Urogynecology Associates, 725 Concord Ave. Suite 1200?

Boston Urogynecology Associates, 725 Concord Ave. Suite 1200 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston Urogynecology Associates, 725 Concord Ave. Suite 1200 conducted?

Boston Urogynecology Associates, 725 Concord Ave. Suite 1200 has 1 clinical trials on record. Their work covers Cystoscopy, Phenazopyridine.

Is Boston Urogynecology Associates, 725 Concord Ave. Suite 1200 accredited by Crixeo Clinical Trials?

Boston Urogynecology Associates, 725 Concord Ave. Suite 1200 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston Urogynecology Associates, 725 Concord Ave. Suite 1200?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.